Russian COVID-19 Vaccine, Sputnik V Shows 92% Success in Phase III Clinical Trials
Posted by
www.biotecnika.org
Russian COVID-19 Vaccine Reports 92% Success The Russian COVID-19
vaccine invention by Pfizer and BioNTech revealed that their product
is beyond 90% effective in curbing the contagion. The pertinent
information is drawn from the Phase III clinical trial's interluding
review. There weren't many details in the testimony issued by the RDIF
and appeared just two […]
The post Russian COVID-19 Vaccine, Sputnik V Shows 92% Success in
Phase III Clinical Trials appeared first on Rasayanika .
https://www.rasayanika.com/2020/11/18/the-russian-covid-19-vaccine-proves-92-efficacy/
News
Subscribe to:
Post Comments (Atom)
Post a Comment